Trial Profile
a phase II trial of amrubicin and carboplatin for patients with extensive stage small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Amrubicin (Primary) ; Carboplatin (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 07 May 2008 New trial record.